In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery.

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

SAN FRANCISCO, June 18 (Reuters) - SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia (NVDA.O), opens new tab, on Wednesday released a trove of data it ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2. “In ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages ...

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...

Researchers at Purdue University have developed an AI platform that accelerates scientific and drug discovery in an an AI-powered lab. In Gaurav Chopra’s lab, discovery starts with a conversation with ...

If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you, it couldn’t dream up one like Xaira Therapeutics. The company emerged ...